Your browser doesn't support javascript.
loading
Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine.
Tsui, Judith I; Mayfield, Jim; Speaker, Elizabeth C; Yakup, Sawir; Ries, Richard; Funai, Harvey; Leroux, Brian G; Merrill, Joseph O.
Afiliação
  • Tsui JI; Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA. Electronic address: tsuij@uw.edu.
  • Mayfield J; Washington State Department of Social and Health Services, Olympia, WA, USA.
  • Speaker EC; Washington State Department of Social and Health Services, Olympia, WA, USA.
  • Yakup S; Washington State Department of Social and Health Services, Olympia, WA, USA.
  • Ries R; Department of Psychiatry, University of Washington School of Medicine, Seattle, WA, USA.
  • Funai H; Washington State Health Care Authority, Olympia, WA.
  • Leroux BG; Department of Biostatistics, University of Washington, Seattle, WA, USA.
  • Merrill JO; Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
J Subst Abuse Treat ; 109: 80-85, 2020 02.
Article em En | MEDLINE | ID: mdl-31810594
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Centros de Tratamento de Abuso de Substâncias / Estimulantes do Sistema Nervoso Central / Metanfetamina / Transtornos Relacionados ao Uso de Opioides Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Centros de Tratamento de Abuso de Substâncias / Estimulantes do Sistema Nervoso Central / Metanfetamina / Transtornos Relacionados ao Uso de Opioides Idioma: En Ano de publicação: 2020 Tipo de documento: Article